ArticleBlood cancer journal2022

Prognostic impact of the AML ELN2022 risk classification in patients undergoing allogeneic stem cell transplantation.

Madlen Jentzsch et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.